When you’re pregnant, your blood contains fragments of your baby’s DNA. A non-invasive prenatal test (NIPT) is a new type of screening test that analyses this circulating DNA in a sample of your blood to predict the risk of your baby having certain genetic abnormalities. Collecting your blood sample for NIPT poses no threat to your baby. inqaba biotec offers through its partner Sequenom laboratories 3 distinct NIPT tests:
Non-invasive prenatal testing (NIPT) was pioneered by Sequenom Laboratories in 2011, and since then, several hundred thousand pregnant women worldwide have benefited. Many have avoided potentially unnecessary invasive procedures while still gaining important information about the health of their pregnancies.
With Sequenom Laboratories’ recent scientific advancements, they have enabled non-invasive prenatal testing to reach even more pregnant women looking for relevant genetic information about their pregnancy.
Sequenom Laboratories is the first provider to offer three distinct non-invasive prenatal testing choices with the MaterniT GENOME, MaterniT21 PLUS and the VisibiliT laboratory-developed tests. MaterniT GENOME is the most comprehensive NIPT to date and has shown to deliver up to 25% more clinically relevant chromosomal information than other NIPT.